Skip to main content

gastroenteritis - Dientamoebiasis (Dientamoeba fragilis)

Advices

1 months - 18 years
Priority Medication Remarks
Priority:
1st choice
Medication:

Remarks:

SWAB remarks

Niet behandelen.

General comments

Pathogeniciteit van deze darmprotozoa is zeer omstreden, behandeling is dus in principe niet geindiceerd.

BEHANDELING

 

Sources

  1. Pubmed.gov publication # 16380293

    Stark DJ, Beebe N, Marriott D, Ellis JT, Harkness J (2006) Dientamoebiasis: clinical importance and recent advances. Trends Parasitol. 22(2):92-6.

  2. http://ac.els-cdn.com/S2211320712000127/1-s2.0-S2211320712000127-main.pdf?_tid=8042ed40-7172-11e3-81db-00000aab0f02&acdnat=1388422414_e0df1ce2f55d9d6edc83f968eabbaff4

    van Hellemond JJ, Molhoek N, Koelewijn R, Wismans PJ, van Genderen PJJ (2012) Is paromomycin the drug of choice for eradication of Dientamoeba fragilis in adults? Int. J. Parasitol.: Drugs Drug Res. 2, 162-165

  3. http://www.mimg.ucla.edu/faculty/campbell/drugs_for_parasites.pdf

    CDC, Medical Letter 2004, Treatment of parasitic infections

  4. Pubmed.gov publication # 4270059

    Oakley GP 1973. The neurotoxicity of the halogenated hydroxyquinolines. A commentary. JAMA 225:395-7.

  5. SWAB Guideline IX - Acute infectieuze diarree
Menu position
Metadata

Swab vid: G-272393.3
Updated: 09/03/2019 - 12:41
Status: Published